Influence of NAD+ as an ageing-related immunomodulator on COVID19 infection: A hypothesis

Huda M. Omran, Mohamed S. Almaliki

Published on June 7, 2020 - Journal of Infection and Public Health
This article, published by Elsevier, says:

  • Elderly COVID-19 patients are at a real risk of complications due to impaired immune function, cytokine storm and defective respiratory function. Administration of anti-ageing immunomodulation factors like Nicotinamide Adenine Dinucleotide NAD+ can minimize these changes through its potent immunomodulation and longevity effects.” (emphasis added)
  • …We suggested the use of NAD+ as an immunomodulator for COVID-19 in older patients. Restoring normal NAD+ levels could decrease the severity of immune reaction in those patients and improve their clinical condition..." (emphasis added)

Read the full article

Topics: